(Q40633555)

22 September 2017

1 reference

title

Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance (English)

1 reference

22 September 2017

0 references

Staphylococcus aureus

1 reference

inferred from title

Pseudomonas aeruginosa

1 reference

Dalhoff A

1

1 reference

22 September 2017

publication date

1 January 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

22 Suppl 2

1 reference

22 September 2017

page(s)

S111-21

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01793575

22 September 2017

exact match

0 references

cites work

Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Increasing resistance of Staphylococcus aureus to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01793575

Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.

21 January 2018

1 reference

12 December 2020

Quinolone/ureidopenicillin cross-resistance

1 reference

12 December 2020

Bacterial resistance to fluoroquinolones

1 reference

12 December 2020

Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.

1 reference

12 December 2020

Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo

1 reference

12 December 2020

Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia

1 reference

12 December 2020

Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.

1 reference

12 December 2020

Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency.

1 reference

12 December 2020

Ciprofloxacin-resistant methicillin-sensitive Staphylococcus aureus

1 reference

12 December 2020

Hospital dispersion of Staphylococcus epidermidis isolates resistant to a fluoroquinolone, pefloxacin

1 reference

12 December 2020

Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization

1 reference

12 December 2020

Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection.

1 reference

12 December 2020

Ciprofloxacin (BAY 09867): clinical evaluation in urinary tract infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Worldwide clinical data on efficacy and safety of ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

Development of new antibiotic resistance in methicillin-resistant but not methicillin-susceptible Staphylococcus aureus

1 reference

12 December 2020

Resistance to ciprofloxacin appearing during therapy

1 reference

12 December 2020

Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin.

1 reference

12 December 2020

Activity of amoxycillin clavulanic/acid against Escherichia coli in vivo

1 reference

12 December 2020

The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis

1 reference

12 December 2020

Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus.

1 reference

12 December 2020

Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolat

1 reference

12 December 2020

Resistance development to fluoroquinolones in Europe

1 reference

12 December 2020

Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization

1 reference

12 December 2020

Clinical Perspectives of Quinolone Resistance in Pseudomonas aeruginosa

1 reference

12 December 2020

Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit

1 reference

12 December 2020

Mechanisms of Fluoroquinolone Resistance in Staphylococcus aureus

1 reference

12 December 2020

The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo

1 reference

12 December 2020

A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods

1 reference

12 December 2020

Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal

1 reference

12 December 2020

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Ciprofloxacin-resistant Staphylococcus aureus

1 reference

12 December 2020

Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane.

1 reference

12 December 2020

Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group

1 reference

12 December 2020

Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.

1 reference

12 December 2020

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

1 reference

12 December 2020

Susceptibility of Pseudomonas aeruginosa to fluoroquinolones following four years of use in a tertiary care hospital

1 reference

12 December 2020

Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.

1 reference

12 December 2020

Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli

1 reference

12 December 2020

Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria.

1 reference

12 December 2020

Epidemiological study of Staphylococcus aureus resistance to new quinolones in a university hospital

1 reference

12 December 2020

Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis

1 reference

12 December 2020

Molecular epidemiology of Pseudomonas aeruginosa--urinary tract infections in paraplegic patients

1 reference

12 December 2020

The clinical problems of bacterial resistance to the new quinolones

1 reference

12 December 2020

Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01793575

1 reference

22 September 2017

1 reference